Redeye comments briefly on Sleep Cycle's decision to CE mark its sleep apnea risk detection solution...
Late last week, it was announced that BONESUPPORT has entered into a distribution agreement with Str...
In August, Gofore continued to deliver monthly sales data slightly ahead of our estimate.
Redeye comments on Magle's announcement that the board has resolved on the directed set-off issue to...
The positive readout today clears the way for the next stage of the trial and the start of a second ...
Redeye comments on today's announcement that OncoZenge has filed a new medical use patent applicatio...
Redeye comments on Better Collective’s announcement of a partnership with Yahoo Sports which will in...
Nyligen släppte Västra Hamnen sin första analys av Precise Biometrics efter fusionen med Fingerprint...
Redeye analyst Oscar Bergman gives a brief introduction to our most recently initiated company, BiBB...
* AI is increasing demand for hardware-based storage infrastructure * NetApp confirmed Dell's report...
Freemelt has received a major order which will kick-start its new business area Manufacturing.
QBIM redovisade ett förbättrat Q2 med högre intäkter, stärkt bruttomarginal och lägre kostnadsbas.
Inderes reported August sales in line with our estimate (rounded).
First project-specific ADES agreement strengthens industrialisation path.
Svedbergs har framgångsrikt transformerats till en internationell badrumskoncern via förvärv och sta...
* The merger approved, the rights issue completed * Investing in profitable growth * Our fair value...
Rekapitalisering gav andrum men underliggande resultat svagt.
Redeye comments on SSH's announcement of a PrivX deployment with one of the world's largest banks, w...
SynAct Pharma has reported further analysis of the Phase IIb ADVANCE study (testing resomelagon in r...
Redeye returns with an update following Saniona's Q2 update and recent events in the company.
